Skip to menu Skip to content Skip to footer

2007

Journal Article

Silibinin inhibits renal cell carcinoma via mechanisms that are independent if insulin-like growth factor-binding protein 3

Cheung, Catherine W., Vesey, David A., Nicol, David L. and Johnson, David W. (2007). Silibinin inhibits renal cell carcinoma via mechanisms that are independent if insulin-like growth factor-binding protein 3. BJU International, 99 (2), 454-460. doi: 10.1111/j.1464-410X.2007.06571.x

Silibinin inhibits renal cell carcinoma via mechanisms that are independent if insulin-like growth factor-binding protein 3

2007

Conference Publication

Follow-up of 15 years of live donors in a large Australian renal transplant unit

Kaisar, M. O., Isbel, N., Hawley, C., Johnson, D., Mudge, D., Griffin, A., Wall, D., Preston, J., Nicol, D. and Campbell, S. (2007). Follow-up of 15 years of live donors in a large Australian renal transplant unit. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell.

Follow-up of 15 years of live donors in a large Australian renal transplant unit

2007

Conference Publication

TRAFs, CARDs and CIDEs are novel apoptotic gene families in therapy-treated renal cell carcinoma and potential diagnostic markers

Rajandram, R., Pat, B. K., Li, J., Percy, C. J., Johnson, D. W. and Gobe, G. C. (2007). TRAFs, CARDs and CIDEs are novel apoptotic gene families in therapy-treated renal cell carcinoma and potential diagnostic markers. National Cancer Research Institute Conference, Birmingham, England, 2-5 October, 2007.

TRAFs, CARDs and CIDEs are novel apoptotic gene families in therapy-treated renal cell carcinoma and potential diagnostic markers

2007

Conference Publication

The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy

Li, J., Vesey, D. A., Johnson, D. W. and Gobe, G. C. (2007). The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy. 32nd Lorne Conference on Protein Structure and Function, Lorne, Victoria, Australia, 4-8 February 2007. Lorne, Vic., Australia:

The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy

2007

Conference Publication

Hospital admission rates in alternate nightly nocturnal home haemodialysis

Van Eps, C. L., Jeffries, J. K., Ng, T. G., Isbel, N. M., Johnson, D. W., Campbell, S. B., Mudge, D. W. and Hawley, C. M. (2007). Hospital admission rates in alternate nightly nocturnal home haemodialysis. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell.

Hospital admission rates in alternate nightly nocturnal home haemodialysis

2007

Conference Publication

Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients

Hourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Ghandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients. American Transplant Congress 2007, USA, 5-9 May 2007. UK: Wiley-Blackwell Publising Ltd.. doi: 10.1111/j.1600-6143.2007.01811.x

Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients

2007

Journal Article

Administration of erythropoietin and its derivatives in renal disease: advantages, mechanisms and concerns

Gobe, Glenda C., Endre, Zoltan H. and Johnson, David W. (2007). Administration of erythropoietin and its derivatives in renal disease: advantages, mechanisms and concerns. Drug Discovery Today: Therapeutic Strategies, 4 (1), 79-84. doi: 10.1016/j.ddstr.2007.07.001

Administration of erythropoietin and its derivatives in renal disease: advantages, mechanisms and concerns

2007

Book Chapter

Hypokalaemia and Metabolic Alkalosis

Johnson, David W. (2007). Hypokalaemia and Metabolic Alkalosis. Clinical Cases in Kidney Disease. (pp. 1-1) edited by D.C.H. Harris. North Ryde, NSW Australia: McGraw-Hill Australia.

Hypokalaemia and Metabolic Alkalosis

2007

Conference Publication

MSC protect renal tubular epithelium from oxidative stress in vitro: support for a protective or regenerative role in acute renal failure

Liu, H., McTaggart S., Johnson, D. W. and Gobe, G. C. (2007). MSC protect renal tubular epithelium from oxidative stress in vitro: support for a protective or regenerative role in acute renal failure. World Congress of Nephrology 2007 (WCN2007), Rio de Janeiro, Brazil, 21-25 April 2007. International Society of Nephrology.

MSC protect renal tubular epithelium from oxidative stress in vitro: support for a protective or regenerative role in acute renal failure

2007

Conference Publication

The effect of diabetes mellitus on access related infection in both peritoneal dialysis and haemodialysis patients

Clark, C. J., Johnson, D., Hawley, C., May, K., Campbell, S., Isbel, N., Mudge, D. and Burke, J. (2007). The effect of diabetes mellitus on access related infection in both peritoneal dialysis and haemodialysis patients. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell.

The effect of diabetes mellitus on access related infection in both peritoneal dialysis and haemodialysis patients

2007

Conference Publication

Mycophenolic acid AUC on day 5 post-renal transplant and related outcomes in the early post-operative period

Staatz, Christine, Wong, Jenny, Taylor, Paul, Johnson, David and Tett, Susan (2007). Mycophenolic acid AUC on day 5 post-renal transplant and related outcomes in the early post-operative period. 10th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology, Nice, France, 9-14 September, 2007. New York: Lippincott-Raven. doi: 10.1097/FTD.0b013e31813797e8

Mycophenolic acid AUC on day 5 post-renal transplant and related outcomes in the early post-operative period

2007

Journal Article

Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with periotoneal dialysis

Craven, Ann-Maree S., Hawley, Carmel M., McDonald, Stephen P., Rosman, Johan B., Brown, Fiona G. and Johnson, David W. (2007). Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with periotoneal dialysis. Peritoneal Dialysis International, 27 (2), 184-191. doi: 10.1177/089686080702700216

Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with periotoneal dialysis

2007

Journal Article

Erythropoietin administration protects against functional impairment and cell death after ischaemic renal injury in pigs

Forman, Colin J., Johnson, David W. and Nicol, David L. (2007). Erythropoietin administration protects against functional impairment and cell death after ischaemic renal injury in pigs. BJU International, 99 (1), 162-165. doi: 10.1111/j.1464-410X.2006.06505.x

Erythropoietin administration protects against functional impairment and cell death after ischaemic renal injury in pigs

2007

Conference Publication

The prevalence of obesity in CKD

Frazier, J., Johnson, D., Hawley, C., Campbell, S., Mudge, D., Van Eps, C., Isbel, N. and Leslie, J. (2007). The prevalence of obesity in CKD. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell.

The prevalence of obesity in CKD

2007

Conference Publication

Adverse outcomes in alternate nightly home nocturnal haemodialysis

van Eps, Carolyn, Jeffries, Janine, Isbel, Nicole, Johnson, David, Campbell, Scott, Mudge, David and Hawley, Carmel (2007). Adverse outcomes in alternate nightly home nocturnal haemodialysis. 44th ERA-EDTA Congress, Barcelona, Spain, 22-24 June 2007 . Oxford, United Kingdom: Oxford University Press.

Adverse outcomes in alternate nightly home nocturnal haemodialysis

2007

Journal Article

Mineral metabolism, bone histomorphometry and vascular calcification in alternate night nocturnal haemodialysis

Van Eps, Carolyn, Jeffries, Janine K., Anderson, John A., Bergin, Patrick T., Johnson, David W., Campbell, Scott B., Carpenter, Sally M., Isbel, Nicole M., Mudge, David W. and Hawley, Carmel M. (2007). Mineral metabolism, bone histomorphometry and vascular calcification in alternate night nocturnal haemodialysis. Nephrology, 12 (3), 224-233. doi: 10.1111/j.1440-1797.2006.00712.x

Mineral metabolism, bone histomorphometry and vascular calcification in alternate night nocturnal haemodialysis

2007

Book

Chronic kidney disease (CKD) management in general practice

Chadban, Steve, Harvie, Barb, Johnson, David Wayne, Joyner, Beres, Kidney Check Australia Taskforce, Kidney Health Australia, Ludlow, Marie, Mathew, Tim, Snelling, Paul, Usherwood, Tim, Weekes, Andrew and Wilmot, Sheena (2007). Chronic kidney disease (CKD) management in general practice. Melbourne, Vic., Australia: Kidney Health Australia.

Chronic kidney disease (CKD) management in general practice

2007

Conference Publication

What is the optimal fat mass in peritoneal dialysis patients?

Johnson, David W. (2007). What is the optimal fat mass in peritoneal dialysis patients?. 11th Congress of the International Society for Peritoneal Dialysis, Hong Kong, 25 - 29 August, 2006. Milton, Ontario: Multimed.

What is the optimal fat mass in peritoneal dialysis patients?

2007

Conference Publication

Peritonitis in Australian peritoneal dialysis patients: Microbiology, treatment and outcomes

Ghali, J., McDonald, S., Bannister, K. M., ANZDATA Peritonitis Working Group and Johnson, D. W. (2007). Peritonitis in Australian peritoneal dialysis patients: Microbiology, treatment and outcomes. Nephrology 2007: 43rd Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Gold Coast, QLD, Australia, 8-12 September 2007. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2007.00847.x

Peritonitis in Australian peritoneal dialysis patients: Microbiology, treatment and outcomes

2007

Conference Publication

Molecular and cellular changes associated with age-related chronic kidney disease

Percy, C., Brown, L., Power, D., Johnson, D. W. and Gobe, G. C. (2007). Molecular and cellular changes associated with age-related chronic kidney disease. International Society of Nephrology's World Congress of Nephrology 2007, Rio de Janeiro, Brazil, 21-25 April 2007.

Molecular and cellular changes associated with age-related chronic kidney disease